Agios Pharmaceuticals | AGIO - Los Ingresos Por Intereses





Los Ingresos Por Intereses Cambio Fecha
AbbVie USD 72M 13M 2026-03
Agios Pharmaceuticals USD 10.8M 1.62M 2026-03
Alnylam Pharmaceuticals USD 26.6M 32K 2026-03
Arrowhead Research USD 9.69M 637K 2025-12
Astellas Pharma JPY 4.12B 2.94B 2024-03
AstraZeneca USD 73M 62M 2026-03
Bayer EUR 169M 39M 2025-12
Biogen USD 37.9M 700K 2026-03
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Daiichi Sankyo JPY 9.96B 230M 2024-03
Eli Lilly USD 65M 25M 2025-09
Exelixis USD 16.13M 1.3M 2026-03
Gilead Sciences USD 95M 7M 2025-12
GlaxoSmithKline GBP 22M 96M 2026-03
Incyte USD 33.69M 2.93M 2026-03
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Merck USD 69M 27M 2025-12
Moderna USD 72M 2M 2026-03
Nektar Therapeutics USD -0.18 0.07 2024-09
Pfizer USD 115M 51M 2026-03
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 183.3M 200K 2026-06
Sarepta Therapeutics USD 8.74M 359K 2025-12
Vertex Pharmaceuticals USD 114.8M 7.1M 2026-03